Published in:
01-10-2020 | Concise Research Report
Research Waste in Randomized Clinical Trials: a Cross-Sectional Analysis
Authors:
Alexander R Zheutlin, Joshua Niforatos, Eric Stulberg, Jeremy Sussman
Published in:
Journal of General Internal Medicine
|
Issue 10/2020
Login to get access
Excerpt
Randomized clinical trials (RCT) require substantial investments from patients, investigators, and funding agencies. RCTs that fail to be completed or to report findings represent research waste, and unnecessary patient harm. Determining RCT viability is critical in allocating funds, and
ClinicalTrials.gov provides a platform for investigators to post results from completed RCTs irrespective of “success,” which can influence publication.
1 We sought to describe research waste in Phase 3 RCTs as indicated by inability to reach completion and insufficient reporting of results when completed. …